These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9322981)

  • 1. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans.
    Montanari A; Tateo E; Fasoli E; Giberti D; Perinotto P; Novarini A; Dall'Aglio P
    Hypertension; 1997 Sep; 30(3 Pt 2):557-62. PubMed ID: 9322981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans.
    Montanari A; Tateo E; Fasoli E; Donatini A; Cimolato B; Perinotto P; Dall'Aglio P
    Hypertension; 1998 Jan; 31(1 Pt 2):277-82. PubMed ID: 9453316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
    Adachi Y; Hashimoto K; Hisa H; Yoshida M; Suzuki-Kusaba M; Satoh S
    Eur J Pharmacol; 1996 Jul; 308(2):165-71. PubMed ID: 8840128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II and prostaglandin interactions on systemic and renal effects of L-NAME in humans.
    Perinotto P; Biggi A; Carra N; Orrico A; Valmadre G; Dall'aglio P; Novarini A; Montanari A
    J Am Soc Nephrol; 2001 Aug; 12(8):1706-1712. PubMed ID: 11461943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
    Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II.
    Baylis C; Engels K; Samsell L; Harton P
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F74-8. PubMed ID: 8430832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the renin-angiotensin system to short-term blood pressure variability during blockade of nitric oxide synthesis in the rat.
    Gouédard O; Blanc J; Gaudet E; Ponchon P; Elghozi JL
    Br J Pharmacol; 1996 Nov; 119(6):1085-92. PubMed ID: 8937709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
    Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes.
    Suanarunsawat T; Klongpanichapak S; Chaiyabutr N
    Diabetes Obes Metab; 1999 Nov; 1(6):339-46. PubMed ID: 11225650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by alpha1-adrenoceptor antagonism.
    van der Linde NA; Boomsma F; van den Meiracker AH
    J Hypertens; 2005 May; 23(5):1017-24. PubMed ID: 15834288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockade blunts the renal effects of acute nitric oxide synthase inhibition in healthy humans.
    Montanari A; Lazzeroni D; Pelà G; Crocamo A; Lytvyn Y; Musiari L; Cabassi A; Cherney DZI
    Am J Physiol Renal Physiol; 2017 May; 312(5):F870-F878. PubMed ID: 28179255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
    Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner HR
    Hypertension; 1993 Sep; 22(3):339-47. PubMed ID: 8349327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.
    Richer C; Domergue V; Vincent MP; Giudicelli JF
    Br J Pharmacol; 1996 Jan; 117(2):315-24. PubMed ID: 8789385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
    van der Linde NA; van den Meiracker AH; Boomsma F
    J Hypertens; 2003 Feb; 21(2):345-51. PubMed ID: 12569265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan attenuates modest but not strong renal vasoconstriction induced by nitric oxide inhibition.
    Turkstra E; Braam B; Koomans HA
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):593-600. PubMed ID: 9781927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats.
    Lee BH; Shin HS
    Jpn J Pharmacol; 1997 May; 74(1):83-90. PubMed ID: 9195301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.